Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow

被引：2
|
作者：
Baertsch, M. A. [1 ]
Lutz, R. [1 ]
Raab, M. S. [1 ,2 ]
Weinhold, N. [1 ]
Goldschmidt, H. [1 ,3 ]
机构：
[1] Univ Hosp Heidelberg, Hematol Oncol & Rheumatol, Heidelberg, Germany
[2] German Canc Res Ctr, Clin Cooperat Unit Mol Hematol Oncol, Heidelberg, Germany
[3] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 2019年 / 145卷 / 10期
关键词：
Multiple myeloma; Minimal residual disease; Immunotherapy; Single-cell sequencing; MINIMAL RESIDUAL DISEASE; SALVAGE AUTOLOGOUS TRANSPLANT; MULTIPLE-MYELOMA; CELL TRANSPLANTATION; SURVIVAL BENEFIT; CONSENSUS; RECOMMENDATIONS; DEXAMETHASONE; LENALIDOMIDE; DARATUMUMAB;
D O I：
10.1007/s00432-019-02998-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose The 7th Heidelberg Myeloma Workshop was held on April 5th and 6th, 2019 at the University Hospital Heidelberg. Methods and results Main topics of the meeting were (1) diagnostics and prognostic factors, (2) role of immunotherapy in multiple myeloma (MM), (3) current therapy of MM, (4) biology and genomics of MM as well as (5) novel treatment concepts. A debate on the status of minimal residual disease (MRD) driven therapy was held. Conclusion Diagnostics and treatment of newly diagnosed and relapsed MM are continuously evolving. While advances in the field of (single cell) genetic analysis now allow for characterization of the disease at an unprecedented resolution, immunotherapeutic approaches and MRD testing are at the forefront of the current clinical trial landscape.
引用
收藏
页码：2445 / 2455
页数：11
相关论文
共 50 条
  • [1] Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow
    M. A. Baertsch
    R. Lutz
    M. S. Raab
    N. Weinhold
    H. Goldschmidt
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2445 - 2455
  • [2] Meeting report of the 5th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma
    Merz, Maximilian
    Hillengass, Jens
    Goldschmidt, Hartmut
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (01) : 247 - 251
  • [3] Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma
    Merz, Maximilian
    Raab, Marc S.
    Goldschmidt, Hartmut
    Hillengass, Jens
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (12) : 2521 - 2526
  • [4] Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma
    Maximilian Merz
    Marc S. Raab
    Hartmut Goldschmidt
    Jens Hillengass
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 2521 - 2526
  • [5] Meeting report of the 4th Heidelberg Myeloma Workshop: Current status and developments in diagnosis and therapy of multiple myeloma
    Jens Hillengass
    Merz Maximilian
    Hartmut Goldschmidt
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1807 - 1811
  • [6] Meeting report of the 5th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma
    Maximilian Merz
    Jens Hillengass
    Hartmut Goldschmidt
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 247 - 251
  • [7] REPORT OF 7TH CLEVELAND MEETING
    TAYLOR, RL
    SCIENCE, 1964, 143 (360) : 835 - &
  • [8] Meeting report of the 4th Heidelberg Myeloma Workshop: Current status and developments in diagnosis and therapy of multiple myeloma
    Hillengass, Jens
    Maximilian, Merz
    Goldschmidt, Hartmut
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (11) : 1807 - 1811
  • [9] REPORT ON THE 7TH EUROPEAN TOKAMAK PROGRAM WORKSHOP
    ENGELMANN, F
    PLASMA PHYSICS AND CONTROLLED FUSION, 1989, 31 (11) : 1823 - 1842
  • [10] REPORT ON THE 7TH WORKSHOP ON CHILDRENS THEATER IN HALLE
    PIETZSCH, I
    THEATER DER ZEIT, 1991, 46 (02): : 46 - 49
12345